Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke

Stroke is an enormous public health problem with an imperative need for more effective therapies. In therapies for ischemic stroke, tissue plasminogen activators, antiplatelet agents and anticoagulants are used mainly for their antithrombotic effects. However, free radical scavengers, minocycline an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Kiyoshi, Uchikado, Hisaaki, Morioka, Motohiro, Murai, Yoshinaka, Tanaka, Eiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397556/
https://www.ncbi.nlm.nih.gov/pubmed/22837724
http://dx.doi.org/10.3390/ijms13067739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397556/
https://www.ncbi.nlm.nih.gov/pubmed/22837724
http://dx.doi.org/10.3390/ijms13067739

Ejemplares similares